Global Non-invasive Prenatal Testing Market to Grow at 17.50% CAGR from 2014 and 2022
Obtain Report Details @ http://www.transparencymarketresearch.com/noninvasive-prenatal-diagnostics-market.html
MaterniT21 (now known as MaterniT21 PLUS) was the first NIPT launched in October 2011 by U.S.-based Sequenom, Inc. Since then, it has led the market, accounting for the largest share in terms of revenue as well as volume (number of tests performed in a year). However, BGI’s NIFTY is expected to outperform MaterniT21 PLUS in terms of volume in the global market by the end of 2014. Sequenom, Inc. is likely to maintain its leadership position in North America through 2022. Harmony, verifi, Panorama, informaSeq, VisibiliT, PrenaTest, and BambniTest are the other commercially available NIPTs for detecting chromosomal abnormalities.
The exponential growth of the NIPT market is supported by factors such as high incidence rate of babies born with Down syndrome, no risk of miscarriage with NIPT, and shifting trend toward child bearing at advanced maternal age (35 years or older). Maternal age is closely associated with the risk of developing a fetus with chromosomal abnormalities; hence, rising maternal age is likely to contribute to the increasing incidence of babies born with chromosomal aneuploidies.
According to Down Syndrome Education (DSE), the incidence rate for Down syndrome is one in every 830 child births (around 4,700 annually) in the U.S., while the incidence rate is one in every 920 babies born (around 9,000 annually) in Europe, indicating a large potential consumer base for NIPT. Conventional invasive prenatal genetic tests such as amniocentesis and chorionic villus sampling (CVS) are associated with the risk of miscarriage; hence, these are being replaced with new non-invasive prenatal tests. These new NIPTs are based on the analysis of cell-free DNA floating in the maternal plasma and pose no risk of miscarriage.
North America held the largest share of the global NIPT market in terms of revenue as well as volume in 2013, accounting for 58.8% and 51.0%, respectively, of the market. Major players domiciled in the U.S. and relatively high awareness levels about NIPT in North America are the key factors attributed to the region’s leadership position. In Europe, market growth largely depends upon increasing penetration of these U.S.-based test developers and increase in acceptance of these tests.
Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=374
Japan, Australia, China, and India represent high growth potential markets in Asia-Pacific. Large population of women preferring late pregnancy is likely to act as a major driver of the NIPT market in the region. The NIPT market in China is dominated by two local players: BGI Diagnostics and Berry Genomics. In addition, the recent CFDA approval for BambniTest would propel the growth of the market in this region.
Sequenom, Inc., Illumina, Inc. (Verinata Health, Inc.), Ariosa Diagnostics, Natera, Inc., BGI Health, LifeCodexx AG, LabCorp, and Berry Genomics are the key players competing in the non-invasive prenatal testing market. These players operate by marketing their proprietary non-invasive prenatal tests by forming alliances with hospitals, clinical laboratories, and physician offices.
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Transparency Market Research
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Non-invasive Prenatal Testing Market to Grow at 17.50% CAGR from 2014 and 2022 here
News-ID: 545773 • Views: 257
More Releases from Transparency Market Research
Powder Coatings Market to Reach US$ 16,203.14 Mn by 2026 Need for Increased Agri …
The demand within the global powder coatings market is slated to grow by leaps and bounds in the years to follow. The need for coating several materials and products with protective layers has played a vital role in the growth of the global powder coatings market. Request Overview - https://www.transparencymarketresearch.com/powder-coatings-market.html Furthermore, advancements in organic as well as polymer chemistry have paved way for key developments within the market. Several industrial manufacturers acknowledge
Fumigation Products Market to Reach a Value of US$ 1.2 Bn by 2027-Lack of Awaren …
Fumigation Products Market: Key Highlights The global fumigation products market was valued at ~US$ 820 Mn in 2018, and is anticipated to expand at a CAGR of ~4% during the forecast period. The global fumigation products market is driven by the rise in the demand for warehouses/storage and residential applications North America accounts for a major share of the global fumigation products market, led by an increase in the demand for residential housing,
Inks Market will Generate Revenue of US$ 21.2 Bn by 2027- Technological Advancem …
Global Inks Market: Key Highlights The global inks market was valued at ~US$ 15.9 Bn in 2018, and is anticipated to expand at a CAGR of ~3% from 2019 to 2027. Rise in population and urbanization is fueling global trade, and subsequently, the use of packaging. Online trade is further increasing the need for packaging. Products are also being consumed immediately, which is driving the need for food service packaging and
Zinc-Bromine Battery Market to Reach Value US$ 23 Mn by 2027 Enhancing Storage i …
The global zinc-bromine battery market was valued at ~US$ 5 Mn in 2018, and is anticipated to expand at a CAGR of ~18% from 2019 to 2027, according to a new research report published by Transparency Market Research (TMR). Increase in the demand for zinc-bromine batteries in power distribution applications is one of the major factors driving the zinc-bromine battery market. In terms of consumption, Asia Pacific accounted for a
More Releases for NIPT
Non-invasive Prenatal Testing (NIPT) Market - Screening Opportunities 2025
Global Non-invasive Prenatal Testing (NIPT) Market: Overview The growing preference for non-invasive techniques over invasive surgeries is one of the key growth drivers for the global non-invasive prenatal testing (NIPT) market. In addition to this number of babies born with Down syndrome, XYY syndrome, Turner, and Klinefelter is increasing, boosting the growth of the market. These chromosomal aneuploidies occur as a result of infertility, reproductive loss, and language development delays
United States Non-Invasive Prenatal Testing (NIPT) Market 2023
United States Non-Invasive Prenatal Testing (NIPT) Industry United States Non-Invasive Prenatal Testing (NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Latest Report on Non-Invasive Prenatal Testing (NIPT) Market United States Analysis & 2023 Forecast Research Study Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk
Non-invasive Prenatal Testing (NIPT) Market | Forecast up to 2022
Global Non-invasive Prenatal Testing Market: Snapshot Non-invasive prenatal testing (NIPT) has been garnering higher adoption especially in the cases of high risk pregnant women. Chromosomal disorders such as Edwards syndrome, down syndrome, Turner syndrome, and Patau syndrome are some of the diseases that can be screened using non-invasive prenatal testing. Gynecologists and pregnant women prefer the safety, non-invasiveness, and accuracy of non-invasive prenatal testing technology, although there are other testing techniques
2017 - 2021 : NIPT Test Market & Forecast
The Potential Non-Invasive Prenatal Testing(NIPT) Market is expected to reach more than USD 4 Billion across the 15 major markets(15MM) by the year end of 2021. Buy Now @: www.dpiresearch.com/report-details.php?P_ID=93 Long–term Growth Projection: More than 2.5 Million tests will be conducted by the 11 major NIPT test by the year end of 2021. Non-Invasive Prenatal Testing (NIPT) market size was valued at nearly USD 1 Billion in 2016 and market is expected to grow
2017-2023 : US NIPT Test Market
United States Non-Invasive Prenatal Testing(NIPT) Market is likely to reach nearly USD 1 Billion by the year end of 2023. Buy Now @ http://www.dpiresearch.com/report-details.php?P_ID=100 Market growth can be attributed to factors such as rapid penetration of high and average risk NIPT test, high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT, shifting trend towards child bearing at advanced maternal age (35 years or older), launch of
Indian NIPT Market Outlook 2022
ReportsWorldwide has announced the addition of a new report title Indian NIPT Market Outlook 2022 to its growing collection of premium market research reports. NIPT helps obstetricians and pregnant women over different age-groups to better manage their pregnancy at a very early stage. Over the last few years, an increasing number of women in Tier-1 cities in India are giving preference to their career, and are opting for childbearing at a